8thAnnual Global Pharma Regulatory Summit 2019

The Indian pharma industry is showing signs of healthy growth and is likely to be in the top 10 global markets by value by 2020. Over the past year, there have been interventions at the regulatory level such as compulsory licensing, FDI policy, marketing code and regulatory approvals, which requires better planning for future growth.

Majority of India pharma companies have reported disappointing results in 2018 compared to last year. Analysts believe the sharp drop in margins are due to regulatory and pricing challenges in global market in addition to the changes created by GST implementation in India. The Indian pharma industry has been facing several regulatory challenges which require careful consideration by the companies as they think through suitable strategies in their pursuit of growth.

Join us at the 8th Annual Global Pharma Regulatory Summit scheduled to be held in Mumbai on 29 to 31 May 2019 as this unique platform is designed to host key leaders and experts of regulatory affairs, compliances, quality assurance and policy makers to discuss the current trends and challenges in global regulatory landscape.

The Conference program will include dialogues and discussions on Brexit, GDPR, third party operation, post-approval changes and life-cycle management, challenges of regulatory application submissions. Attendees will also learn about current topics, such as changing face of pharma legislation, impact of technologies on regulatory system, regulatory landscape of South America, and many others.


Glimpses of 2017

Key Features
  • Standalone presentations by renowned speakers on changing regulatory aspects of Americas, UK and Europe
  • A day dedicated to discuss the business opportunities in emerging markets such as China and Southern America
  • Panel Discussions on Brexit and GDPR
  • Dialogues describing the best practices for registration across the USA, UK and RoW
  • Explore the synergy among the global stakeholders of Pharma
Programme Focus/ Key Topics
  • India Pharma Vision 2020 and changing global landscape
  • Evolving regulatory scenario of USA
  • Registration process and pain points of South America
  • Brexit and GDPR - Where to we stand
  • A global perspective of emerging markets
  • China's regulatory reform
  • Third party operation management

Past Event Partners

Silver Partner

Exhibit Partners

Media Partners

Subscribe To Our Newsletter